Login to Your Account



Lilly Vows To Appeal $65.2M Win By Ariad In Patent Fight

By Randall Osborne


Friday, May 5, 2006
Ariad Pharmaceuticals Inc.'s stock jumped after news of a victory valued at about $65.2 million in its patent lawsuit against Eli Lilly and Co. - though Lilly plans first to ask the judge to set aside the jury's verdict regarding Evista and Xigris and then to appeal, if necessary. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription